Transmission (Mosquito Vector, Cattle)
In terms of transmission, the mosquito vector segment is anticipated to hold a prominent share of 70% in the global rift valley fever (RVF) treatment market during the forecast period on account of the higher proximity of infection transmission through mosquitoes, along with the lack of preventive methods in case of mosquito vector transmission. There is no requirement for direct contact with animals in case of transmission by mosquitoes, which makes it more dangerous and easier to spread. Such factors are estimated to boost the segment growth. Additionally, as the mosquitos are becoming the primary transmission route the rift valley fever prevention strategies increasingly target mosquito control. This further drive demand for insecticides, mosquito nets, and larvicides as a result driving the segment growth in this market.
Treatment (Medication, Supportive Care)
The medication segment in the rift valley fever treatment market is predicted to hold the largest revenue share of 60% by the end of 2036. Several promising antiviral drugs are in the development pipeline for rift valley fever. These target different stages of the viral replication cycle, offering the potential for more effective treatment. The successful development and commercialization of these drugs would significantly boost the medication segment of the market. Medication for fever and pain alleviation can be used to treat symptoms of the moderate type of RVF; however, individuals coming with severe symptoms are not yet treated with any specific or approved therapies.
Our in-depth analysis of the global market includes the following segments:
Transmission |
|
Symptoms |
|
Distribution Channel |
|
Treatment |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?